(c) 2024 PillSync.com

Levothyroxine Sodium 0.125 MG Oral Tablet

1 INDICATIONS AND USAGE Hypothyroidism Levothyroxine Sodium Tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine Sodium Tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use Levothyroxine Sodium Tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with Levothyroxine Sodium Tablets may induce hyperthyroidism [see Warnings and Precautions ( 5.1 )] . Levothyroxine Sodium Tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. Levothyroxine Sodium Tablets are L-thyroxine (T4) indicated in adult and pediatric patients, including neonates, for: Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. ( 1 ) Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. ( 1 ) Limitations of Use not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis

alvogen, inc.


4 years ago OVAL BROWN 125 T 4 Levothyroxine Sodium 0.125 MG Oral Tablet

OVAL BROWN 125 T 4

16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied

LEVOTHYROXINE SODIUM Tablets, in the shape of caplet are supplied as follows (Table 11): Table 11.

LEVOTHYROXINE SODIUM Tablet Presentations Strength (mcg) Color Tablet Markings NDC# for bottles of 90 NDC# for bottles of 1,000 25 mcg orange "T|4" and "25" 47781-640-90 47781-640-10 50 mcg white "T|4" and "50" 47781-643-90 47781-643-10 75 mcg violet "T|4" and "75" 47781-646-90 47781-646-10 88 mcg Mint green "T|4" and "88" 47781-649-90 47781-649-10 100 mcg yellow "T|4" and "100" 47781-651-90 47781-651-10 112 mcg Rose "T|4" and "112" 47781-654-90 47781-654-10 125 mcg brown "T|4" and "125" 47781-657-90 47781-657-10 137 mcg Deep blue "T|4" and "137" 47781-659-90 47781-659-10 150 mcg Light blue "T|4" and "150" 47781-662-90 47781-662-10 175 mcg lilac "T|4" and "175" 47781-665-90 47781-665-10 200 mcg pink "T|4" and "200" 47781-668-90 47781-668-10 300 mcg green "T|4" and "300" 47781-671-90 47781-671-10 Storage and Handling Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C and 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect

LEVOTHYROXINE SODIUM Tablets from light and moisture.


More pills like OVAL 125 T 4












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site